| Divis Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532488 |
NSE Symbol : DIVISLAB |
P/E(TTM) : 73.09 |
|
ISIN Demat : INE361B01024 |
Div & Yield% : 0.36 |
EPS(TTM) : 112.85 |
|
Book Value(₹) : 629.49 |
Market Cap(₹Cr) : 218,971.76 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,974.00 | 2,793.00 | 2,578.00 | 2,660.00 | 2,357.00 | 2,536.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,974.00 | 2,793.00 | 2,578.00 | 2,660.00 | 2,357.00 | 2,536.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 63.00 | 154.00 | 87.00 | 146.00 | 119.00 | 87.00 |
| Total Income | 3,037.00 | 2,947.00 | 2,665.00 | 2,806.00 | 2,476.00 | 2,623.00 |
| Total Expenditure | 1,734.00 | 1,850.00 | 1,745.00 | 1,765.00 | 1,614.00 | 1,655.00 |
| PBIDT | 1,303.00 | 1,097.00 | 920.00 | 1,041.00 | 862.00 | 968.00 |
| Interest | 6.00 | 6.00 | 6.00 | 8.00 | 3.00 | 0.00 |
| PBDT | 1,297.00 | 1,091.00 | 914.00 | 1,033.00 | 859.00 | 968.00 |
| Depreciation | 132.00 | 120.00 | 116.00 | 113.00 | 112.00 | 107.00 |
| Tax | 290.00 | 250.00 | 208.00 | 220.00 | 191.00 | 225.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -16.00 | -35.00 | -8.00 | 4.00 | -1.00 | -31.00 |
| Reported Profit After Tax | 891.00 | 756.00 | 598.00 | 696.00 | 557.00 | 667.00 |
| Extra-ordinary Items | 0.00 | 0.00 | -54.71 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 891.00 | 756.00 | 652.71 | 696.00 | 557.00 | 667.00 |
| EPS (Unit Curr.) | 33.55 | 28.44 | 22.56 | 26.24 | 20.95 | 25.12 |
| EPS (Adj) (Unit Curr.) | 33.55 | 28.44 | 22.56 | 26.24 | 20.95 | 25.12 |
| Calculated EPS (Unit Curr.) | 33.62 | 28.53 | 22.57 | 26.26 | 21.02 | 25.17 |
| Calculated EPS (Adj) (Unit Curr.) | 33.62 | 28.53 | 22.57 | 26.26 | 21.02 | 25.17 |
| Calculated EPS (Ann.) (Unit Curr.) | 134.49 | 114.11 | 90.26 | 105.06 | 84.08 | 100.68 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 134.49 | 114.11 | 90.26 | 105.06 | 84.08 | 100.68 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 43.81 | 39.28 | 35.69 | 39.14 | 36.57 | 38.17 |
| PBDTM(%) | 43.61 | 39.06 | 35.45 | 38.83 | 36.44 | 38.17 |
| PATM(%) | 29.96 | 27.07 | 23.20 | 26.17 | 23.63 | 26.30 |
